Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SIAIS213110 |
Target |
Action inhibitors, degraders |
Mechanism BRD2 inhibitors(Bromodomain-containing protein 2 inhibitors), BRD3 inhibitors(Bromodomain-containing protein 3 inhibitors), BRD4 degraders(Bromodomain-containing protein 4 degraders) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC37H39ClN8O4S |
InChIKeyUYBVSBAZZWUPHH-XLTVJXRZSA-N |
CAS Registry1883863-65-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | China | 08 May 2019 |